Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001185185-14-000776
Filing Date
2014-03-31
Accepted
2014-03-31 16:51:36
Documents
9
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 10-K avtherapeutics10k123113.htm 10-K 1053615
2 EX-31.1 ex31-1.htm EX-31.1 17288
3 EX-32.1 ex32-1.htm EX-32.1 8202
  Complete submission text file 0001185185-14-000776.txt   5128037

Data Files

Seq Description Document Type Size
4 EX-101.INS avth-20131231.xml EX-101.INS 578861
5 EX-101.SCH avth-20131231.xsd EX-101.SCH 50778
6 EX-101.CAL avth-20131231_cal.xml EX-101.CAL 37246
7 EX-101.DEF avth-20131231_def.xml EX-101.DEF 233531
8 EX-101.LAB avth-20131231_lab.xml EX-101.LAB 356562
9 EX-101.PRE avth-20131231_pre.xml EX-101.PRE 235835
Mailing Address 20 EAST 68TH STREET, SUITE 204 NEW YORK NY 10065
Business Address 20 EAST 68TH STREET, SUITE 204 NEW YORK NY 10065 917-497-5523
AV Therapeutics, Inc. (Filer) CIK: 0001537293 (see all company filings)

EIN.: 331222799 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-55149 | Film No.: 14730722
SIC: 2040 Grain Mill Products